Amgen subsidiary deCODE Genetics has identified new risk factors and genes associated with clonal hematopoiesis, a precursor state to blood cancer. In the results of a study published Nov. 6 in Nature ...
Scientists at deCODE genetics, a subsidiary of AMGEN, have discovered rare sequence variants, predicted to cause a loss of function of ITSN1, that are associated with a high risk of Parkinson‘s ...
Sequence variants that protect against pericarditis have been discovered at a genomic locus encoding interleukin-1 immune cytokines. A newly approved drug treatment for pericarditis inhibits these ...
Ten years after acquiring deCODE Genetics, Amgen’s collaboration with the Icelandic genetic sleuths has only blossomed, expanding from drug discovery to clinical development. The partners celebrated ...
REYKJAVIK, Iceland, Jan. 29, 2024 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Iceland, Denmark, and the USA published a study today in Nature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results